🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Introducing LongitudeDX: Understanding Changes in Health Over Time longitudedx.com

Waters’ latest product launch will supercharge the role of #MassSpectrometry research in the fight against #SARSCoV2. Read the blog today: bit.ly/3yC1zcS #Covid19Research #LCMS

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more! vimeo.com/124121614

Please be sure to join us alongside one of our business partners, SISCAPA, for a PharmaVoice virtual panel on September 8th at 1:00pm ET register.gotowebinar.com/register/78960…

We hope you’ll join us at 1:00 ET on Sept. 8th for a free virtual panel as CDS’ Jeff Rogers explores a new approach for real-world, continuous data collection and how it applies to #decentralizedtrials alongside SISCAPA Assay Technologies and Merck. register.gotowebinar.com/register/78960…

Did you miss our virtual panel on September 8th where we discussed a new approach for real-time continuous data collection and the future of #decentralizedtrials? Check out the on-demand recording here! crucialdatasolutions.com/videos/#longit…

Overcome the limitations of your ligand binding assay with custom #SISCAPA protein assay & panel development! siscapa.com/customassays

View our presentation to see how frequent longitudinal sampling of biomarkers can help understand changes in health over time! prezi.com/view/tMyNRGzAm…

SISCAPA(R) technology radically improves the sensitivity and throughput of mass spectrometry-based protein tests through specific enrichment of selected target peptides from sample digests. siscapa.com/blog/2021/5/31…

The motivation for measuring inflammation is simple: inflammation is central to the understanding of human health and disease. siscapa.com/blog/measuring…

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more! vimeo.com/124121614

Learn more about how working with Crucial Data Solutions has allowed SISCAPA to seamlessly collect data for longitudinal health studies. crucialdatasolutions.com/case-study/sis…

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more! vimeo.com/124121614

This new article, from Ghent University, features the use of SISCAPA technology in the development of a SARS-CoV-2 LC-MS assay! medrxiv.org/content/10.110…

Congratulations Dr. Cameron! It is a pleasure for SISCAPA Assay Technologies to collaborate with the Cameron Lab on this project. uvic.ca/news/topics/20…

youtube.com/watch?v=XXw_AS…

New “gold-standard” test for COVID-19 developed by commercial-academic partnership between #UVic microbiologist Caroline Cameron and SISCAPA thanks to NSERC / CRSNG #COVID19 Alliance Grant. 👉ow.ly/LCBc50IMMN6 UVic Research UVic Science #UnivResearch

"I oversee the dev. of diagnostic tests for UVic-SISCAPA projects. I've known Caroline for about 10 yrs: she's an esteemed scientist & simply an outstanding person. There's no one I'd rather collaborate with." 🔬Matt Pope(he/him), SISCAPA General Manager uvic.ca/news/academics…

“The biggest takeaway from my UVic Co-op + Career with SISCAPA is an appreciation for the importance & complexity of developing an accurate diagnostic test for any disease. I'll continue my research as a #UVic Honours student with Dr. Cameron this Fall.” 🔬Angela Mitchell (she/her)

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets. Watch the 2 min overview video to learn more! vimeo.com/124121614